Growth differentiation factor 15 acts anti‐apoptotic and pro‐hypertrophic in adult cardiomyocytes
- 23 April 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 224 (1), 120-126
- https://doi.org/10.1002/jcp.22102
Abstract
Growth differentiation factor 15 (GDF15) is induced during heart failure development, and may influence different processes in cardiac remodeling. While its anti-apoptotic action under conditions of ischemia–reperfusion have been shown, it remained unclear if this is a broadly protective effect applicable to other apoptotic stimuli. Furthermore, effects on cardiac hypertrophy remained obscure. Therefore, we investigated the effects of GDF15 on induction of hypertrophy and apoptosis in ventricular cardiomyocytes. GDF15 (3 ng/ml) enhanced hypertrophic growth of cardiomyocytes as determined by an increase in cell size by 27 ± 5% and rate of protein synthesis by 47 ± 15%. In addition, a time and dose-dependent increase in SMAD-binding affinity was found, as well as enhanced phosphorylation of R-SMAD1. Inhibition of SMADs by transformation of cardiomyocytes with SMAD-decoy oligonucleotides abolished the hypertrophic growth effect. Specific inhibitors of PI3K (10 µM LY290042 or 10 nM wortmannin) or ERK (10 µM PD98059) also blocked GDF15-induced hypertrophy and SMAD activation. Apoptosis induction by three different agents, 100 nM angiotensin II, 1 ng/ml TGFβ1, or the NO-donor SNAP (100 µM) was blocked by addition of GDF15 (3 ng/ml). Scavenging of SMADs by transformation of cardiomyocytes with SMAD-decoy oligonucleotides abolished the anti-apoptotic effect of GDF15. In conclusion, GDF15 protects ventricular cardiomyocytes against different apoptotic stimuli and enhances hypertrophic growth. Hypertrophic signaling is thereby mediated via the kinases PI3K and ERK and the transcription factor R-SMAD1. Thus, GDF15 may influence cardiac remodeling via two different mechanisms, apoptosis protection and induction of hypertrophy. J. Cell. Physiol. 224:120–126, 2010Keywords
This publication has 27 references indexed in Scilit:
- The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion InjuryCirculation Research, 2006
- GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein ActivationCirculation Research, 2006
- BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-κB activationJournal of Bone and Mineral Metabolism, 2005
- SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytesCardiovascular Research, 2005
- Smad1 Protects Cardiomyocytes From Ischemia-Reperfusion InjuryCirculation, 2005
- Elevated Levels of Activin A in Heart FailureCirculation, 2004
- Bone Morphogenetic Protein-2 Inhibits Serum Deprivation-induced Apoptosis of Neonatal Cardiac Myocytes through Activation of the Smad1 PathwayJournal of Biological Chemistry, 2001
- Myostatin, a transforming growth factor-? superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarctJournal of Cellular Physiology, 1999
- Alpha- and Beta-Adrenergic Stimulation of Protein Synthesis in Cultured Adult Ventricular CardiomyocytesJournal of Molecular and Cellular Cardiology, 1993
- Comparing the Means of Several GroupsThe New England Journal of Medicine, 1985